Emily Nash Smyth

3PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 08, 2023
Clinical and Genomic Characteristics of Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors.

Xi Rao, Yongmei Chen, Julie Beyrer

|Sep 13, 2022
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2- Metastatic Breast Cancer Treated with Abemaciclib.

Emily Nash Smyth, Julie Beyrer, Kimberly R Saverno

|Mar 27, 2016
Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer.

Emily Nash Smyth, Wei Shen, Lee Bowman

Pageof 1

Frequent Collaborators

2 joint publications

Julie Beyrer

2 joint publications

Garreth W Lawrence

1 joint publications

Kimberly R Saverno

1 joint publications

Xi Rao